发明名称 COMPOSITION FOR SOLID PHARMACEUTICAL PREPARATION OF SOLIFENACIN OR SALT THEREOF
摘要 A solid pharmaceutical preparation of solifenacin or a salt thereof, the preparation being stable and inhibited from decomposing with time when supplied to clinical fields. In a pharmaceutical preparation containing solifenacin or a salt thereof, the compound in an amorphous form was revealed to be causative of cardinal-drug decomposition with time. The composition for a solid pharmaceutical preparation of solifenacin or a salt thereof contains solifenacin or its salt each in a crystalline form, and the content of the compound in an amorphous form in the composition is within the range which exerts no influence on product stability. Also provided are: a process for producing the composition; and a medicinal composition for solid pharmaceutical preparations which contains solifenacin and an amorphization inhibitor. ® KIPO & WIPO 2007
申请公布号 KR20070010132(A) 申请公布日期 2007.01.22
申请号 KR20067019783 申请日期 2006.09.25
申请人 ASTELLAS PHARMA INC. 发明人 SUGIHARA AKIO;YASUJI TAKEHIKO;MASAKI KATSUHIRO;MURAYAMA DAISUKE
分类号 A61K31/439;A61K9/20;A61K47/34;A61P1/12;A61P13/02;A61P27/08;C07D453/02 主分类号 A61K31/439
代理机构 代理人
主权项
地址